New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).
Breast cancer screening resumes on Bonaire after COVID-19 hiatus Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.
Microplastics in paint can cause problems in the environment Companies and organisations in the paint sector are aware that microplastics can cause problems as these particles end up in the environment where they persist and may be harmful to plants and anim
New WHO protocol for integrated One Health surveillance of antibiotic resistance: the Tricycle protocol The World Health Organization (WHO) has developed a protocol for global One Health surveillance of antimicrobial resistance based on one indicator, Extended Spectrum Beta-Lactamase producing E. WHO
Can you solve a medical mystery? During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.
Measures against polluting microplastics from garments When garments made from synthetic materials wear, due to use and washing, microplastic fibres are released. Wastewater treatment plants remove 50 to 90 per cent of these microplastic fibres.
Sustainability Day at RIVM: Microplastics Today, 10 October 2018, is national Sustainability Day in the Netherlands.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.
Meningococcal type W most notable infectious disease in 2017 The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a